Related Experiment Video
Updated: May 22, 2026

Production and Detection of Reactive Oxygen Species (ROS) in Cancers
Published on: November 21, 2011
The three Rs along the TRAIL: resistance, re-sensitization and reactive oxygen species (ROS)
Gregory Mellier1, Shazib Pervaiz
1Department of Physiology, Yong Loo Lin School of Medicine, Singapore.
Abstract:
Ligation of the Tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) death receptors has been associated with cancer specific apoptotic execution in a number of model systems. This has generated tremendous interest in the use of TRAIL as a potential therapeutic modality. However, recent evidence indicates that resistance to TRAIL might present with a therapeutic challenge. In this short report, we review the basic biology of TRAIL signalling in cancer cells, highlight the mechanisms underlying resistance to TRAIL and the ability of small molecule compounds to re-sensitize cells to TRAIL-mediated apoptosis. In particular, we provide evidence that intracellular reactive oxygen species could be critical in regulating the response of cancer cells to TRAIL.
Insights
Tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) can trigger cancer cell death. However, cancer cells can become resistant to TRAIL, but small molecules and reactive oxygen species may help overcome this resistance.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Therapeutics
Background:
- Tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) pathway induces apoptosis in cancer cells.
- TRAIL-based cancer therapies show promise but face challenges due to resistance.
- Understanding TRAIL resistance mechanisms is crucial for developing effective cancer treatments.
Purpose of the Study:
- To review the biology of TRAIL signaling in cancer.
- To highlight mechanisms of TRAIL resistance in cancer cells.
- To explore small molecule compounds and reactive oxygen species in overcoming TRAIL resistance.
Main Methods:
- Literature review of TRAIL signaling and resistance mechanisms.
- Analysis of studies investigating small molecule compounds for TRAIL sensitization.
- Examination of the role of intracellular reactive oxygen species (ROS) in TRAIL response.
Main Results:
- TRAIL receptor ligation triggers cancer-specific apoptosis in various models.
- Cancer cells can develop resistance to TRAIL-mediated apoptosis.
- Small molecule compounds can re-sensitize cancer cells to TRAIL.
- Intracellular reactive oxygen species (ROS) play a critical role in regulating cancer cell response to TRAIL.
Conclusions:
- TRAIL is a promising cancer therapeutic, but resistance is a significant hurdle.
- Small molecules and modulation of reactive oxygen species (ROS) are potential strategies to enhance TRAIL efficacy.
- Targeting intracellular ROS may be a key approach to overcome TRAIL resistance in cancer therapy.
More Related Videos
05:16High Throughput Screening Assessment of Reactive Oxygen Species (ROS) Generation using Dihydroethidium (DHE) Fluorescence Dye
Published on: January 19, 2024
10:05Stimulation of Stem Cell Niches and Tissue Regeneration in Mouse Skin by Switchable Protoporphyrin IX-Dependent Photogeneration of Reactive Oxygen Species In Situ
Published on: May 8, 2020
Related Concept Videos
Radical Autoxidation
Radical Reactivity: Overview
Oxygen Requirements and Growth Patterns
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Cellular Injury I: Introduction
Redox Reactions